Live Breaking News & Updates on Head Investor Relations Communications

Stay updated with breaking news from Head investor relations communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Santhera Announces Closing of Exclusive North America License Agreement with Catalyst Pharmaceuticals for Vamorolone - Catalyst Pharmaceuticals (NASDAQ:CPRX)

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, July 19, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces the closing of the exclusive license agreement for vamorolone in North America (NA) with ....

United Kingdom , Switzerland General , United States , Dario Eklund , Eva Kalias , Catalyst Pharmaceuticals Inc , Santhera Pharmaceuticals , America To Catalyst Pharmaceuticals , Chiesi Group , Santhera Pharmaceuticals Holding , Life Science Alliance , Regulatory Agency , European Medicines Agency , Head Investor Relations Communications , North America , Catalyst Pharmaceuticals , Highbridge Capital , Chief Executive Officer , Hart Scott Rodino Antitrust Improvements , Orphan Drug , Fast Track , Rare Pediatric Disease , Promising Innovative Medicine , Grants Exclusive North America License , Deal Valued , Proc Natl Acad Sci United States ,

Santhera Pharmaceuticals Holding AG: Santhera Publishes Timeline of the Reverse Share Split

Santhera Pharmaceuticals Holding AG: Santhera Publishes Timeline of the Reverse Share Split
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United Kingdom , Switzerland General , United States , Eva Kalias , Head Investor Relations Communications , European Medicines Agency , Santhera Pharmaceuticals Holding , Santhera Pharmaceuticals , Swiss Exchange , Chiesi Group , Regulatory Agency , International Securities Identification Number , Annual General Meeting , United Kingdom Medicines , North America , Head Investor Relations , Securities Act ,

Santhera Publishes Timeline of the Reverse Share Split

Santhera Publishes Timeline of the Reverse Share Split
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Switzerland General , Eva Kalias , Head Investor Relations Communications , Santhera Pharmaceuticals Holding , Santhera Pharmaceuticals , European Medicines Agency , Swiss Exchange , Regulatory Agency , Chiesi Group , International Securities Identification Number , Publishes Timeline , Reverse Share , Annual General Meeting , United Kingdom Medicines , North America , Head Investor Relations , Securities Act ,

Santhera Pharmaceuticals Holding AG: Shareholders Approve all Board Proposals at Today's Annual General Meeting

Santhera Pharmaceuticals Holding AG: Shareholders Approve all Board Proposals at Today's Annual General Meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland General , Eva Kalias , Patrick Vink , Philipp Gutzwiller , Thomas Meier , Otto Schwarz , Bradleyc Meyer , Bradleyc Meyer Committee , Santhera Pharmaceuticals , Compensation Committee , Head Investor Relations Communications , Santhera Pharmaceuticals Holding , Annual General Meeting , Annual Report , Executive Management , Committee Chairman , Compensation Report , Head Investor Relations ,

Shareholders Approve all Board Proposals at Today's Annual General Meeting

Shareholders Approve all Board Proposals at Today's Annual General Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Switzerland General , United Kingdom , United States , Bradleyc Meyer , Philipp Gutzwiller , Patrick Vink , Eva Kalias , Otto Schwarz , Thomas Meier , Santhera Pharmaceuticals , Bradleyc Meyer Committee , Compensation Committee , Santhera Pharmaceuticals Holding , European Medicines Agency , Head Investor Relations Communications , Regulatory Agency , Chiesi Group , Board Proposals , Annual General , Annual General Meeting , Annual Report , Executive Management , Committee Chairman , Compensation Report , United Kingdom Medicines , North America ,